NFKB1 and Alzheimer disease: Diseased AD brains reduce increased levels of BACE1 and NF-κB p65, and NF-κB p65 leads to increased activity of the BACE1 promoter and BACE1 transcription, while knockout of NF-κB p65 reduces gene expression BACE1 in cells [45].